Calian Group Ltd. · TSX:CGY
Calian — Q1 2023 Earnings Presentation
14 slides from Calian's earnings presentation, Feb 15, 2023
Slide 1: Investor Presentation – Q1 FY23
Investor Presentation – Q1 FY23 February 15, 2023
Slide 2: Caution Regarding Forward Looking Statements
Caution Regarding Forward Looking Statements Certain information included in this document is forward-looking and is subject to important risks and uncertainties. The results or events predicted in these statements may differ materially from actual results or events. Such statements are generally ac
Slide 3: Q1-23 Consolidated Results
Q1-23 Consolidated Results $126M $1.3B -2% 16% New Contract Signings Backlog Organic Growth Acquisitive Growth Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $) (in millions of $, except margin) (in millions of $, except margin) 60 40.0% 161 50 20.0 19.1 142 150 148 46 22.0% 5
Slide 4: Q1-23 ITCS
Q1-23 ITCS $46M $102M 11% 89% New Contract Signings Backlog Organic Growth Acquisitive Growth Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $, except margin) (in millions of $, except margin) (in millions of $) 69 30 65.0% 14.0 35.0% 12.4 25.1 60.0% 25 12.0 55.0% 30.0% 49 46
Slide 5: Q1-23 Health
Q1-23 Health $34M $690M -5% -% New Contract Signings Backlog Organic Growth Acquisitive Growth Revenues Gross Profit & Margin Adj. EBITDA1 & Margin1 (in millions of $, except margin) (in millions of $, except margin) (in millions of $) 10.0 40.0% 35.0% 14.0 9.0 45 7.9 8.0 30.0% 42 12.0 11.0 11.3 8.0
Slide 6: Q1-23 Advanced Technologies
Q1-23 Advanced Technologies $42M $167M -17% -% New Contract Signings Backlog Organic Growth Acquisitive Growth Gross Profit & Margin Adj. EBITDA1 & Margin1 Revenues (in millions of $, except margin) (in millions of $, except margin) (in millions of $) 11.9 45.0% 7.0 12 10.7 11.2 11.2 41 10.2 6.0 5.5
Slide 7: Q1-23 Learning
Q1-23 Learning $4M $307M 16% -% New Contract Signings Backlog Organic Growth Acquisitive Growth Gross Profit & Margin Adj. EBITDA1 & Margin1 Revenues (in millions of $, except margin) (in millions of $) (in millions of $, except margin) 8.0 6.0 40.0% 5.4 26 6.8 6.6 32.0% 25 7.0 23 5.9 5.0 22 22 5.7
Slide 8: Q1-23 - Operating FCF Generation & Conversion
Q1-23 - Operating FCF Generation & Conversion Adj. EBITDA2 Operating Free Cash Flow (OFCF)1&2 OFCF Conversion1&2 (in millions of $) (in millions of $) (in %) 85% 19.1 14.1 78% 74% 16.8 13.1 12.1 70% 16.1 14.0 14.3 63% 9.8 10.2 Q1-22 Q2-22 Q3-22 Q4-22 Q1-23 Q1-22 Q2-22 Q3-22 Q4-22 Q1-23 Q1-22 Q2-22 Q
Slide 9: Q1-23 – Capital Deployment
Q1-23 – Capital Deployment Acquisitions Dividends Capex1 (in millions of $) (in millions of $) (in millions of $) 48 3 3 3 3 3 2 2 2 1 1 10 4 4 3 Q1-22 Q2-22 Q3-22 Q4-22 Q1-23 Q1-22 Q2-22 Q3-22 Q4-22 Q1-23 Q1-22 Q2-22 Q3-22 Q4-22 Q1-23 1) Capex = Equipment and application software + Capitalized R&D
Slide 10: Q1-23 - Balance Sheet
Q1-23- Balance Sheet Total Debt Cash & Cash Equivalents Net Liquidity (in millions of $) (in millions of $) (in millions of $) 147 25 67 131 59 58 124 114 115 51 43 8 8 8 0 Q1-22 Q2-22 Q3-22 Q4-22 Q1-23 Q1-22 Q2-22 Q3-22 Q4-22 Q1-23 Q1-22 Q2-22 Q3-22 Q4-22 Q1-23 1) Net Liquidity= Unused portion of c
Slide 11: FY23 – Guidance Reiterated
FY23 – Guidance Reiterated Revenues Adj. EBITDA1 Adj. Net Profit1 (in millions of $) (in millions of $) (in millions of $) 630-680 70-75 46-50 582 518 66 44 432 52 37 343 37 24 27 19 2019 2020 2021 2022 2023E 2019 2020 2021 2022 2023E 2019 2020 2021 2022 2023E 1) This is a non-GAAP measure. Please r
Slide 12: Concluding Remarks
Record Q1 results for revenues, gross profit and EBITDA Double-digit organic growth for ITCS and Learning Better second half of the year: = Timing of new business wins = New contract signings = Easing of supply chain issues Recent acquisitions are performing well Working hard to close a few acquisit
Slide 13: Question Period
Question Period Kevin Ford Patrick Houston Jennifer McCaughey CEO CFO & Corporate Secretary Director, Investor Relations
Slide 14: Thank you
See CALIAN . Thank you ir@calian.com